Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Details

Connection

Dana Dabelea to Hypoglycemic Agents

This is a "connection" page, showing publications Dana Dabelea has written about Hypoglycemic Agents.

 
Connection Strength
  
 
 
1.664
  
  1. Dabelea D, Ma Y, Knowler WC, Marcovina S, Saudek CD, Arakaki R, White NH, Kahn SE, Orchard TJ, Goldberg R, Palmer J, Hamman RF. Diabetes autoantibodies do not predict progression to diabetes in adults: the Diabetes Prevention Program. Diabet Med. 2014 09; 31(9):1064-8.
    View in: PubMed
    Score: 0.228
  2. Knowler WC, Pan Q, Shu S, Tripputi MT, Dabelea D, Edelstein SL, Kahn SE, Kuo S, Luchsinger JA, Shah V, Wallia A, Temprosa M. Analysis of Long-term Follow-up of a Randomized Clinical Trial With Departures From Assigned Treatments: Estimation of Metformin Effects on Diabetes and Its Complications in the Diabetes Prevention Program Outcomes Study. Diabetes Care. 2025 Oct 01; 48(10):1668-1675.
    View in: PubMed
    Score: 0.126
  3. Heckman-Stoddard BM, Crandall JP, Edelstein SL, Prorok PC, Dabelea D, Hamman R, Hazuda HP, Horton E, Hoskin MA, Perloff M, Bowers A, Knowler WC, Ford LG, Temprosa M. Randomized Study of Metformin and Intensive Lifestyle Intervention on Cancer Incidence over 21 Years of Follow-up in the Diabetes Prevention Program. Cancer Prev Res (Phila). 2025 Jul 01; 18(7):401-411.
    View in: PubMed
    Score: 0.124
  4. Knowler WC, Doherty L, Edelstein SL, Bennett PH, Dabelea D, Hoskin M, Kahn SE, Kalyani RR, Kim C, Pi-Sunyer FX, Raghavan S, Shah VO, Temprosa M, Venditti EM, Nathan DM. Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial. Lancet Diabetes Endocrinol. 2025 Jun; 13(6):469-481.
    View in: PubMed
    Score: 0.123
  5. Goldberg RB, Tripputi MT, Boyko EJ, Budoff M, Chen ZZ, Clark JM, Dabelea DM, Edelstein SL, Gerszten RE, Horton E, Mather KJ, Perreault L, Temprosa M, Wallia A, Watson K, Irfan Z. Hepatic Fat in Participants With and Without Incident Diabetes in the Diabetes Prevention Program Outcome Study. J Clin Endocrinol Metab. 2021 10 21; 106(11):e4746-e4765.
    View in: PubMed
    Score: 0.096
  6. Snyder LL, Stafford JM, Dabelea D, Divers J, Imperatore G, Law J, Lawrence JM, Pihoker C, Mayer-Davis EJ. Socio-economic, demographic, and clinical correlates of poor glycaemic control within insulin regimens among children with Type 1 diabetes: the SEARCH for Diabetes in Youth  Study. Diabet Med. 2019 08; 36(8):1028-1036.
    View in: PubMed
    Score: 0.082
  7. Negrisanu G, Rosu M, Bolte B, Lefter D, Dabelea D. Effects of 3-month treatment with the antioxidant alpha-lipoic acid in diabetic peripheral neuropathy. Rom J Intern Med. 1999 Jul-Sep; 37(3):297-306.
    View in: PubMed
    Score: 0.082
  8. Apolzan JW, Venditti EM, Edelstein SL, Knowler WC, Dabelea D, Boyko EJ, Pi-Sunyer X, Kalyani RR, Franks PW, Srikanthan P, Gadde KM. Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study. Ann Intern Med. 2019 05 21; 170(10):682-690.
    View in: PubMed
    Score: 0.081
  9. Goldberg RB, Aroda VR, Bluemke DA, Barrett-Connor E, Budoff M, Crandall JP, Dabelea D, Horton ES, Mather KJ, Orchard TJ, Schade D, Watson K, Temprosa M. Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium. Circulation. 2017 Jul 04; 136(1):52-64.
    View in: PubMed
    Score: 0.071
  10. Mottl AK, Divers J, Dabelea D, Maahs DM, Dolan L, Pettitt D, Marcovina S, Imperatore G, Pihoker C, Mauer M, Mayer-Davis EJ. The dose-response effect of insulin sensitivity on albuminuria in children according to diabetes type. Pediatr Nephrol. 2016 Jun; 31(6):933-40.
    View in: PubMed
    Score: 0.064
  11. Sullivan SD, Jablonski KA, Florez JC, Dabelea D, Franks PW, Dagogo-Jack S, Kim C, Knowler WC, Christophi CA, Ratner R. Genetic risk of progression to type 2 diabetes and response to intensive lifestyle or metformin in prediabetic women with and without a history of gestational diabetes mellitus. Diabetes Care. 2014 Apr; 37(4):909-11.
    View in: PubMed
    Score: 0.056
  12. Lawrence JM, Black MH, Zhang JL, Slezak JM, Takhar HS, Koebnick C, Mayer-Davis EJ, Zhong VW, Dabelea D, Hamman RF, Reynolds K. Validation of pediatric diabetes case identification approaches for diagnosed cases by using information in the electronic health records of a large integrated managed health care organization. Am J Epidemiol. 2014 Jan 01; 179(1):27-38.
    View in: PubMed
    Score: 0.055
  13. Badaru A, Klingensmith GJ, Dabelea D, Mayer-Davis EJ, Dolan L, Lawrence JM, Marcovina S, Beavers D, Rodriguez BL, Imperatore G, Pihoker C. Correlates of treatment patterns among youth with type 2 diabetes. Diabetes Care. 2014; 37(1):64-72.
    View in: PubMed
    Score: 0.055
  14. Pihoker C, Badaru A, Anderson A, Morgan T, Dolan L, Dabelea D, Imperatore G, Linder B, Marcovina S, Mayer-Davis E, Reynolds K, Klingensmith GJ. Insulin regimens and clinical outcomes in a type 1 diabetes cohort: the SEARCH for Diabetes in Youth study. Diabetes Care. 2013 Jan; 36(1):27-33.
    View in: PubMed
    Score: 0.051
  15. Kim C, Edelstein SL, Crandall JP, Dabelea D, Kitabchi AE, Hamman RF, Montez MG, Perreault L, Foulkes MA, Barrett-Connor E. Menopause and risk of diabetes in the Diabetes Prevention Program. Menopause. 2011 Aug; 18(8):857-68.
    View in: PubMed
    Score: 0.047
  16. Dabelea D, D'Agostino RB, Mason CC, West N, Hamman RF, Mayer-Davis EJ, Maahs D, Klingensmith G, Knowler WC, Nadeau K. Development, validation and use of an insulin sensitivity score in youths with diabetes: the SEARCH for Diabetes in Youth study. Diabetologia. 2011 Jan; 54(1):78-86.
    View in: PubMed
    Score: 0.045
  17. Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, Fowler S, Kahn SE. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab. 2008 Dec; 93(12):4774-9.
    View in: PubMed
    Score: 0.039
  18. Crandall JP, Dabelea D, Knowler WC, Nathan DM, Temprosa M. The Diabetes Prevention Program and Its Outcomes Study: NIDDK's Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact. Diabetes Care. 2025 Jul 01; 48(7):1101-1111.
    View in: PubMed
    Score: 0.031
  19. Lee CG, Ciarleglio A, Edelstein SL, Crandall JP, Dabelea D, Goldberg RB, Kahn SE, Knowler WC, Ma MT, White NH, Herman WH. Prevalence of Distal Symmetrical Polyneuropathy by Diabetes Prevention Program Treatment Group, Diabetes Status, Duration of Diabetes, and Cumulative Glycemic Exposure. Diabetes Care. 2024 May 01; 47(5):810-817.
    View in: PubMed
    Score: 0.029
  20. Goldberg RB, Orchard TJ, Crandall JP, Boyko EJ, Budoff M, Dabelea D, Gadde KM, Knowler WC, Lee CG, Nathan DM, Watson K, Temprosa M. Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study. Circulation. 2022 05 31; 145(22):1632-1641.
    View in: PubMed
    Score: 0.025
  21. Ibfelt EH, Wibaek R, Vistisen D, Andersen GS, Jørgensen ME, Hulman A, Dabelea D, Birkebaek NH, Svensson J, Rønn PF. Trajectory and predictors of HbA1c in children and adolescents with type 1 diabetes-A Danish nationwide cohort study. Pediatr Diabetes. 2022 09; 23(6):721-728.
    View in: PubMed
    Score: 0.025
  22. Kahkoska AR, Sarteau AC, Igudesman D, Reboussin BA, Dabelea D, Dolan LM, Jensen E, Wadwa RP, Pihoker C, Mayer-Davis EJ. Association of Insulin Regimen and Estimated Body Fat Over Time among Youths and Young Adults with Type 1 Diabetes: The SEARCH for Diabetes in Youth Study. J Diabetes Res. 2022; 2022:1054042.
    View in: PubMed
    Score: 0.024
  23. Lee CG, Heckman-Stoddard B, Dabelea D, Gadde KM, Ehrmann D, Ford L, Prorok P, Boyko EJ, Pi-Sunyer X, Wallia A, Knowler WC, Crandall JP, Temprosa M. Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study. Diabetes Care. 2021 12; 44(12):2775-2782.
    View in: PubMed
    Score: 0.024
  24. Roberts AJ, Taplin CE, Isom S, Divers J, Saydah S, Jensen ET, Mayer-Davis EJ, Reid LA, Liese AD, Dolan LM, Dabelea D, Lawrence JM, Pihoker C. Association between fear of hypoglycemia and physical activity in youth with type 1 diabetes: The SEARCH for diabetes in youth study. Pediatr Diabetes. 2020 11; 21(7):1277-1284.
    View in: PubMed
    Score: 0.022
  25. Herman WH, Pan Q, Edelstein SL, Mather KJ, Perreault L, Barrett-Connor E, Dabelea DM, Horton E, Kahn SE, Knowler WC, Lorenzo C, Pi-Sunyer X, Venditti E, Ye W. Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation. Diabetes Care. 2017 12; 40(12):1668-1677.
    View in: PubMed
    Score: 0.018
  26. Kim C, Christophi CA, Goldberg RB, Perreault L, Dabelea D, Marcovina SM, Pi-Sunyer X, Barrett-Connor E. Adiponectin, C-reactive protein, fibrinogen and tissue plasminogen activator antigen levels among glucose-intolerant women with and without histories of gestational diabetes. Diabet Med. 2016 Jan; 33(1):32-8.
    View in: PubMed
    Score: 0.015
  27. Petitti DB, Klingensmith GJ, Bell RA, Andrews JS, Dabelea D, Imperatore G, Marcovina S, Pihoker C, Standiford D, Waitzfelder B, Mayer-Davis E. Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study. J Pediatr. 2009 Nov; 155(5):668-72.e1-3.
    View in: PubMed
    Score: 0.010
  28. Florez JC, Jablonski KA, Kahn SE, Franks PW, Dabelea D, Hamman RF, Knowler WC, Nathan DM, Altshuler D. Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program. Diabetes. 2007 Feb; 56(2):531-6.
    View in: PubMed
    Score: 0.009
  29. Maahs DM, Kinney GL, Wadwa P, Snell-Bergeon JK, Dabelea D, Hokanson J, Ehrlich J, Garg S, Eckel RH, Rewers MJ. Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population. Diabetes Care. 2005 Feb; 28(2):301-6.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)